United Services Automobile Association’s Alder Biopharmaceuticals ALDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-238,335
Closed -$2.81M 2147
2019
Q2
$2.81M Buy
238,335
+2,115
+0.9% +$25.6K 0.01% 999
2019
Q1
$3.22M Buy
236,220
+155,200
+192% +$2.01M 0.01% 952
2018
Q4
$830K Sell
81,020
-5,270
-6% -$67.5K ﹤0.01% 1335
2018
Q3
$1.44M Sell
86,290
-1,170
-1% -$21.1K ﹤0.01% 1221
2018
Q2
$1.38M Sell
87,460
-2,032
-2% -$30.9K ﹤0.01% 1252
2018
Q1
$1.14M Buy
89,492
+8,483
+10% +$123K ﹤0.01% 1313
2017
Q4
$928K Buy
81,009
+3,723
+5% +$41.6K ﹤0.01% 1238
2017
Q3
$947K Buy
77,286
+45,970
+147% +$479K ﹤0.01% 1206
2017
Q2
$359K Buy
31,316
+1,390
+5% +$25.7K ﹤0.01% 1367
2017
Q1
$622K Sell
29,926
-1,195
-4% -$26.5K ﹤0.01% 1163
2016
Q4
$647K Buy
31,121
+780
+3% +$20.3K ﹤0.01% 1168
2016
Q3
$994K Buy
30,341
+9,980
+49% +$304K ﹤0.01% 1104
2016
Q2
$508K Buy
20,361
+3,320
+19% +$89.8K ﹤0.01% 1170
2016
Q1
$417K Buy
+17,041
New +$395K ﹤0.01% 1196

Other funds holding ALDR

United Services Automobile Association's ALDR Position: Q3 2019 in Review

United Services Automobile Association sold out of Alder Biopharmaceuticals (ALDR) in Q3 2019, closing a stake of 238,335 shares — an estimated $2.81M sold.

United Services Automobile Association first reported a position in ALDR in Q1 2016 and held it in 14 quarters. The position peaked at $3.22M in Q1 2019. 143 funds tracked by Wall St. Rank hold ALDR as of Q3 2019.

  • United Services Automobile Association reported no remaining Alder Biopharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • United Services Automobile Association sold 238,335 Alder Biopharmaceuticals shares in Q3 2019, an estimated $2.81M.
  • United Services Automobile Association first reported a position in Alder Biopharmaceuticals in Q1 2016 and held it in 14 quarters.
  • United Services Automobile Association's Alder Biopharmaceuticals position peaked at $3.22M in Q1 2019.
  • 143 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2019.

Based on United Services Automobile Association's 13F filing for Q3 2019, filed 13 Nov 2019.